Table of Contents Author Guidelines Submit a Manuscript
Volume 2012 (2012), Article ID 708042, 4 pages
Research Article

The Prevalence of Polycystic Ovary Syndrome in Women with Idiopathic Intracranial Hypertension

1Department of Ophthalmology, Rabin Medical Center, Beilinson Campus, 49100 Petah Tiqva, Israel
2Sackler Faculty of Medicine, Tel Aviv University, 69918 Tel Aviv, Israel
3Department of Endocrinology, Rabin Medical Center, Beilinson Campus, 49100 Petah Tiqva, Israel

Received 27 May 2012; Accepted 1 July 2012

Academic Editors: M. F. Cordeiro and A. O. L. Wong

Copyright © 2012 Inbal Avisar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Purpose. The purpose of this study is to re-evaluate whether the prevalence of polycystic ovary syndrome (PCOS) amongst women with idiopathic intracranial hypertension (IIH) is higher than in the general population using the NIH criteria. Methods. We included all consecutive women with IIH of child-bearing age seen at a hospital-based neuro-ophthalmology clinic between the years 2000–2005. All consenting women included in this study filled-out a screening questionnaire aimed at identifying women at risk for PCOS. The endocrinologist examined each patient suspect of PCOS as well as their biochemical results and diagnosed PCOS according to NIH criteria. The prevalence of PCOS in these women with IIH was compared with the reported prevalence of PCOS in the general population. Results. Out of 58 women with IIH who completed the study, definite PCOS was diagnosed in nine women (9/58; 15.5%). We found a significantly higher prevalence of PCOS using the NIH criteria among the IHH study group (15.5%, ) compared to the general population (8.7%). Conclusions. The prevalence of PCOS is higher among patients with IHH, compared to the general population. We suggest a novel screening questionnaire to aid in the identification of women with IIH at risk for PCOS.